VIRPA.PHARMACEUT. DL-,001 Logo
US9282511073
A3CMW5
VRPX

VIRPA.PHARMACEUT. DL-,001

Dividend yield TTM
0.00%
€0.00/share
Dividend growth (CAGR 5Y)
-
Next dividend
It is unlikely that any further dividends will be paid.

Upcoming dividends delivered straight to your inbox

Historical dividends

In 2022, VIRPA.PHARMACEUT. DL-,001 has already paid €3.09 in dividends. The last payout was in May 2022.

Tools for dividend investors

Dividend metrics Metrics

All metrics All
Metric Value
Price
€0.0000863
Yield
0.00%
Interval
Yearly
CAGR 3Y
-
CAGR 5Y
-
CAGR 10Y
-

All dividend data

VIRPA.PHARMACEUT. DL-,001 has not paid a dividend in the last 3 years. It is therefore likely that no further dividends will be paid.

New dividends delivered straight to your inbox
Ex-dividend date
Payment date
Distribution
YoY
Yield
2022 €3.09 530.61% 534.89%
05/05/2022 05/11/2022 €3.09
2017 €0.49 0.00% -
11/13/2017 11/17/2017 €0.49

Frequently asked questions

When were the most recent dividend payment dates for VIRPA.PHARMACEUT. DL-,001?

The most recent payment was made on 05/11/2022.

When did you need to hold VIRPA.PHARMACEUT. DL-,001 in your portfolio to receive the latest dividend?

If you held VIRPA.PHARMACEUT. DL-,001 in your portfolio on 05/05/2022, you received the payout.

When is the next dividend from VIRPA.PHARMACEUT. DL-,001 expected?

As VIRPA.PHARMACEUT. DL-,001 has not paid a dividend in the last 3 years, it is unlikely to pay another dividend.

More dividend stocks

All dividends in the calendar
Name Interval
Yield
CAGR 5Y
AstraZeneca Logo
GB0009895292
886455
H 1.94% 3.85%
Accenture Logo
IE00B4BNMY34
A0YAQA
Q 3.42% 13.26%
KION Logo
DE000KGX8881
KGX888
Y 1.38% 82.96%
Starbucks Logo
US8552441094
884437
Q 2.28% 8.11%
KPS Logo
DE000A1A6V48
A1A6V4
- 0.00% -
Texas Instruments Logo
US8825081040
852654
Q 2.18% 8.52%
Samsung GDR (Vz) Logo
US7960502018
881823
Q 0.65% 3.07%
Branicks Logo
DE000A1X3XX4
A1X3XX
- 0.00% -
Weichai Power Logo
CNE1000004L9
A0M4ZC
H 2.58% 20.91%
Credit Suisse (ADR) Logo
US2254011081
911778
- 0.00% -
🍪

Parqet  uses cookies. Learn more